Berberine treatment suppressed the mRNA expression of extracellular matrix–degrading proteinases MMP2 and urokinase-plasminogen activator (u-PA), which are closely associated with the invasive and metastatic potential of lung cancer cells [93,120]. The gene discussed is PLAU; the disease is lung carcinoma.